Molecular Partners Dirección
Dirección controles de criterios 2/4
El CEO de Molecular Partners' es Patrick Amstutz , nombrado en Jan 2004, tiene una permanencia de 20.25 años. compensación anual total es CHF1.05M, compuesta por 36.8% salario y 63.2% primas, incluidas acciones y opciones de la empresa. posee directamente un 2.24% de las acciones de la empresa, por valor de CHF2.35M. La antigüedad media del equipo directivo y de la junta directiva es de 2.7 años y 4 años, respectivamente.
Información clave
Patrick Amstutz
Chief Executive Officer (CEO)
CHF1.0m
Compensación total
| Porcentaje del salario del CEO | 36.8% |
| Permanencia del CEO | 20.3yrs |
| Participación del CEO | 2.2% |
| Permanencia media de la dirección | 2.8yrs |
| Promedio de permanencia en la Junta Directiva | 4.1yrs |
Actualizaciones recientes de la dirección
Recent updates
We Think Some Shareholders May Hesitate To Increase Molecular Partners AG's (VTX:MOLN) CEO Compensation
Apr 11
Is Molecular Partners (VTX:MOLN) In A Good Position To Invest In Growth?
Jan 09Here's Why We're Watching Molecular Partners' (VTX:MOLN) Cash Burn Situation
Sep 08Need To Know: The Consensus Just Cut Its Molecular Partners AG (VTX:MOLN) Estimates For 2023
Jun 23What You Need To Know About The Molecular Partners AG (VTX:MOLN) Analyst Downgrade Today
Aug 31Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans
May 09Upgrade: Analysts Just Made A Substantial Increase To Their Molecular Partners AG (VTX:MOLN) Forecasts
Dec 26We're Hopeful That Molecular Partners (VTX:MOLN) Will Use Its Cash Wisely
Jun 24Molecular Partners AG (VTX:MOLN) Could Be Less Than A Year Away From Profitability
Mar 09Analysts Just Made A Major Revision To Their Molecular Partners AG (VTX:MOLN) Revenue Forecasts
Feb 10Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans
Jan 21How Much Of Molecular Partners AG (VTX:MOLN) Do Insiders Own?
Dec 17
Downgrade: Here's How Analysts See Molecular Partners AG (VTX:MOLN) Performing In The Near Term
Nov 21Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | CHF1m | CHF385k | -CHF62m |
| Sep 30 2023 | n/a | n/a | -CHF60m |
| Jun 30 2023 | n/a | n/a | -CHF62m |
| Mar 31 2023 | n/a | n/a | -CHF50m |
| Dec 31 2022 | CHF1m | CHF383k | CHF118m |
| Sep 30 2022 | n/a | n/a | CHF117m |
| Jun 30 2022 | n/a | n/a | CHF118m |
| Mar 31 2022 | n/a | n/a | CHF106m |
| Dec 31 2021 | CHF1m | CHF380k | -CHF64m |
| Sep 30 2021 | n/a | n/a | -CHF67m |
| Jun 30 2021 | n/a | n/a | -CHF72m |
| Mar 31 2021 | n/a | n/a | -CHF66m |
| Dec 31 2020 | CHF1m | CHF380k | -CHF63m |
| Sep 30 2020 | n/a | n/a | -CHF53m |
| Jun 30 2020 | n/a | n/a | -CHF48m |
| Mar 31 2020 | n/a | n/a | -CHF43m |
| Dec 31 2019 | CHF930k | CHF363k | -CHF36m |
| Sep 30 2019 | n/a | n/a | -CHF37m |
| Jun 30 2019 | n/a | n/a | -CHF38m |
| Mar 31 2019 | n/a | n/a | -CHF38m |
| Dec 31 2018 | CHF909k | CHF346k | -CHF37m |
| Sep 30 2018 | n/a | n/a | -CHF27m |
| Jun 30 2018 | n/a | n/a | -CHF18m |
| Mar 31 2018 | n/a | n/a | -CHF24m |
| Dec 31 2017 | CHF885k | CHF344k | -CHF25m |
Compensación vs. Mercado: La compensación total de Patrick($USD1.15M) está por encima de la media de empresas de tamaño similar en el mercado Swiss ($USD586.02K).
Compensación vs. Ingresos: La compensación de Patrick ha aumentado mientras la empresa no es rentable.
CEO
Patrick Amstutz (48 yo)
20.3yrs
Permanencia
CHF1,047,000
Compensación
Dr. Patrick Amstutz, Ph.D. is a Co-Founder of Molecular Partners AG and has been its Chief Executive Officer since November 2016 and serves as its Member of Management Board since 2004. Dr. Amstutz serves...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder | 20.3yrs | CHF1.05m | 2.24% CHF 2.5m | |
| Co-Founder | 20.3yrs | sin datos | 2.34% CHF 2.6m | |
| Senior VP of Finance | 4.8yrs | sin datos | sin datos | |
| COO & Member of Management Board | 1.8yrs | sin datos | 0.078% CHF 87.4k | |
| Executive VP of People & Community and Member of Management Board | 2.4yrs | sin datos | 0.070% CHF 78.2k | |
| Senior Vice President of Research & Technology | 3.2yrs | sin datos | sin datos | |
| Senior Vice President of Investor Relations | no data | sin datos | sin datos | |
| General Counsel | 1.5yrs | sin datos | sin datos | |
| Strategic Consultant | 4.8yrs | sin datos | sin datos | |
| Senior Vice President of Research & Early Development | 2.3yrs | sin datos | sin datos | |
| Interim Chief Medical Officer | less than a year | sin datos | sin datos |
2.8yrs
Permanencia media
51yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de MOLN se considera experimentado (2.7 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder | 6.6yrs | CHF1.05m | 2.24% CHF 2.5m | |
| Independent Non Executive Director | 10yrs | CHF135.00k | 0.045% CHF 50.0k | |
| Independent Chairman of the Board | 6.6yrs | CHF295.00k | 0.082% CHF 91.6k | |
| Independent Director | 4.1yrs | CHF125.00k | 0.011% CHF 11.9k | |
| Independent Director | 3.1yrs | CHF125.00k | sin datos | |
| Independent Director | 4.1yrs | CHF135.00k | 0.011% CHF 11.9k | |
| Independent Director | 4.1yrs | CHF130.00k | 0.011% CHF 11.9k | |
| Independent Director | 3.1yrs | CHF133.00k | sin datos |
4.1yrs
Permanencia media
58yo
Promedio de edad
Junta con experiencia: La junta directiva de MOLN se considera experimentada (4 años de antigüedad promedio).